Zhang Q - Search Results

1

Surface expression of anti-CD3scfv stimulates locoregional immunotherapy against hepatocellular carcinoma depending on the E1A-engineered human umbilical cord mesenchymal stem cells.

Zhang Q, Yuan XF, Lu Y, Li ZZ, Bao SQ, Zhang XL, Yang YY, Fan DM, Zhang YZ, Wu CX, Guo HX, Zhang YJ, Ye Z, Xiong DS. Zhang Q, et al. Among authors: zhang xl, zhang yz, zhang yj. Int J Cancer. 2017 Oct 1;141(7):1445-1457. doi: 10.1002/ijc.30846. Epub 2017 Jul 7. Int J Cancer. 2017. PMID: 28643325 Free article.

2

The additive effects of combined murine nuclear migration protein with murine thrombopoietin in vitro and in vivo on normal and myelosuppressed mice.

Duan XY, Yang Y, Zhang Q, Ge YC, Xu P. Duan XY, et al. Among authors: zhang q. Int J Hematol. 2011 Jul;94(1):44-53. doi: 10.1007/s12185-011-0828-5. Epub 2011 Jun 7. Int J Hematol. 2011. PMID: 21647609

3

Redirection of CD4+ and CD8+ T lymphocytes via an anti-CD3 × anti-CD19 bi-specific antibody combined with cytosine arabinoside and the efficient lysis of patient-derived B-ALL cells.

Fan D, Li W, Yang Y, Zhang X, Zhang Q, Yan Y, Yang M, Wang J, Xiong D. Fan D, et al. Among authors: zhang q, zhang x. J Hematol Oncol. 2015 Oct 6;8:108. doi: 10.1186/s13045-015-0205-6. J Hematol Oncol. 2015. PMID: 26444983 Free PMC article.

4

E1A-engineered human umbilical cord mesenchymal stem cells as carriers and amplifiers for adenovirus suppress hepatocarcinoma in mice.

Li Z, Ye Z, Zhang X, Zhang Q, Fan D, Zhang Y, Luo HR, Yuan X, Li Z, Xiong D. Li Z, et al. Among authors: zhang q, zhang x, zhang y. Oncotarget. 2016 Aug 9;7(32):51815-51828. doi: 10.18632/oncotarget.10122. Oncotarget. 2016. PMID: 27322080 Free PMC article.

5

Mesenchymal stem cells deliver and release conditionally replicative adenovirus depending on hepatic differentiation to eliminate hepatocellular carcinoma cells specifically.

Yuan X, Zhang Q, Li Z, Zhang X, Bao S, Fan D, Ru Y, Dong S, Zhang Y, Zhang Y, Ye Z, Xiong D. Yuan X, et al. Among authors: zhang q, zhang x, zhang y. Cancer Lett. 2016 Oct 10;381(1):85-95. doi: 10.1016/j.canlet.2016.07.019. Epub 2016 Jul 20. Cancer Lett. 2016. PMID: 27450327

6

Mesenchymal stromal cells as vehicles of tetravalent bispecific Tandab (CD3/CD19) for the treatment of B cell lymphoma combined with IDO pathway inhibitor D-1-methyl-tryptophan.

Zhang X, Yang Y, Zhang L, Lu Y, Zhang Q, Fan D, Zhang Y, Zhang Y, Ye Z, Xiong D. Zhang X, et al. Among authors: zhang l, zhang q, zhang y. J Hematol Oncol. 2017 Feb 23;10(1):56. doi: 10.1186/s13045-017-0397-z. J Hematol Oncol. 2017. PMID: 28228105 Free PMC article.

7

miR-335 inhibited cell proliferation of lung cancer cells by target Tra2β.

Liu J, Bian T, Feng J, Qian L, Zhang J, Jiang D, Zhang Q, Li X, Liu Y, Shi J. Liu J, et al. Among authors: zhang q, zhang j. Cancer Sci. 2018 Feb;109(2):289-296. doi: 10.1111/cas.13452. Epub 2017 Dec 15. Cancer Sci. 2018. PMID: 29161765 Free PMC article.

8

Cetuximab functionalization strategy for combining active targeting and antimigration capacities of a hybrid composite nanoplatform applied to deliver 5-fluorouracil: toward colorectal cancer treatment.

Chen R , Huang Y , Wang L , Zhou J , Tan Y , Peng C , Yang P , Peng W , Li J , Gu Q , Sheng Y , Wang Y , Shao G , Zhang Q , Sun Y . Chen R , et al. Among authors: zhang q. Biomater Sci. 2021 Mar 21;9(6):2279-2294. doi: 10.1039/d0bm01904f. Epub 2021 Feb 4. Biomater Sci. 2021. PMID: 33538278

9

Effectiveness and Safety of Dabrafenib in the Treatment of 20 Chinese Children with BRAFV600E-Mutated Langerhans Cell Histiocytosis.

Yang Y, Wang D, Cui L, Ma HH, Zhang L, Lian HY, Zhang Q, Zhao XX, Zhang LP, Zhao YZ, Li N, Wang TY, Li ZG, Zhang R. Yang Y, et al. Among authors: zhang l, zhang lp, zhang r, zhang q. Cancer Res Treat. 2021 Jan;53(1):261-269. doi: 10.4143/crt.2020.769. Epub 2020 Sep 15. Cancer Res Treat. 2021. PMID: 32972045 Free PMC article.

10

Prognostic value of decreased GRK6 expression in lung adenocarcinoma.

Yao S, Zhong L, Liu J, Feng J, Bian T, Zhang Q, Chen J, Lv X, Chen J, Liu Y. Yao S, et al. Among authors: zhang q. J Cancer Res Clin Oncol. 2016 Dec;142(12):2541-2549. doi: 10.1007/s00432-016-2244-y. Epub 2016 Sep 6. J Cancer Res Clin Oncol. 2016. PMID: 27601164

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

64,740 results

Search Page